Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia

Alzheimer’s disease (AD) is the primary type of dementia, followed by frontotemporal lobar degeneration (FTLD). They share some clinical characteristics, mainly at the early stages. So, the identification of early, specific, and minimally invasive biomarkers is required. In this study, some plasma b...

Full description

Bibliographic Details
Main Authors: Lourdes Álvarez-Sánchez, Carmen Peña-Bautista, Laura Ferré-González, Angel Balaguer, Miguel Baquero, Bonaventura Casanova-Estruch, Consuelo Cháfer-Pericás
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Alzheimer’s disease
frontotemporal dementia
plasma
biomarker
SIMOA
diagnosis
Online Access:https://www.mdpi.com/1422-0067/24/2/1226

Internet

https://www.mdpi.com/1422-0067/24/2/1226

Similar Items